SPL UNCLASSIFIED SECTION Gastrointestinal Adverse Reactions In a pool of Study 1 and 2, gastrointestinal adverse reactions occurred more frequently among patients receiving ZEPBOUND (5 mg 56%, 10 mg 56%, 15 mg 56%) than placebo (30%)
Elevate your skincare regimen and embrace a brighter, more luminous complexion.
Special situations and considerations Injecting during weight loss As you lose weight on retatrutide, your body composition changes
Backed by data from the Phase IIIb STEP UP clinical trial, Wegovy HD 7.2mg demonstrated impressive weight loss outcomes while maintaining a safety profile consistent with lower-dose semaglutide treatment
Combined with optional Precision Peptide Genetic Testing ($298), PlexusDx creates a tailored, affordable pathway to sustainable weight loss even after gallbladder removal
de Oliveira MG, Thompson LD, Chaves AC, Rados PV, da Silva Lauxen I, Filho MS